- Series
- CDSNS Colloquium
- Time
- Monday, October 19, 2009 - 11:00am for 1 hour (actually 50 minutes)
- Location
- Skiles 269
- Speaker
- Redouane Qesmi – York University, Canada and SoM, Georgia Tech
- Organizer
- Yingfei Yi
Despite advances in treatment of chronic hepatitis B virus (HBV) infection,
liver transplantation remains the only hope for many patients with end-stage
liver disease due to HBV. A complication with liver transplantation,
however, is that the new liver is eventually reinfected in chronic HBV
patients by infection in other compartments of the body. We have formulated
a model to describe the dynamics of HBV after liver transplant, considering
the liver and the blood of areas of infection. Analyzing the model, we
observe that the system shows either a transcritical or a backward
bifurcation. Explicit conditions on the model parameters are given for the
backward bifurcation to be present, to be reduced, or disappear.
Consequently, we investigate possible factors that are responsible for
HBV/HCV infection and assess control strategies to reduce HBV/HCV
reinfection and improve graft survival after liver transplantation.